February 6, 2014
Hepatitis C (HCV) infection can be a confusing disease for patients without proper guidance from their care providers. Due to the complex nature of the virus, its effects on the body and our rapidly evolving treatment options, it can also be difficult for providers to answer questions in a way that resonates with their patients.
Fortunately, at TheBody.com -- TheBodyPRO.com's sister site for the general community -- answering patient questions is what we do. Whether they are concerned about transmission or want to know about managing and treating the disease, our resident hepatitis expert, Lynn E. Taylor, M.D., F.A.C.P., A.A.H.I.V.S., an assistant professor of medicine in the division of infectious diseases at Brown University and attending physician at the Miriam Hospital in Providence, R.I., is there to fill in the gaps.
Here are a collection of answers to some of the most frequently asked questions we see about HCV on TheBody.com. These Q&As provide the necessary context and information to help create a better-informed patient.
|Taking Atripla Three Days a Week Maintains Undetectable HIV Viral Load, Pilot Study Finds|
|Which HIV Treatment Regimens Are Recommended for Newly Diagnosed Patients?|
|Weekly PRO 140 Antibody Injections May Work as HIV Maintenance Therapy|
|This Week in HIV Research: Effects of Treatment on Arterial Inflammation; Mortality Rate After 5 Years of Treatment Not Impacted by Initial CD4 Count|
|Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study|